LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

Search

ResMed Inc

Open

SectorHealthcare

226.61 -1.62

Overview

Share price change

24h

Current

Min

218.53

Max

231.69

Key metrics

By Trading Economics

Income

44M

393M

Sales

87M

1.4B

P/E

Sector Avg

22.833

57.833

Dividend yield

0.98

Profit margin

27.593

Employees

10,600

EBITDA

63M

566M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+29.8% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.98%

2.47%

Next Earnings

22 Apr 2026

Next Dividend date

11 Jun 2026

Next Ex Dividend date

7 May 2026

Market Stats

By TradingEconomics

Market Cap

-3.6B

34B

Previous open

228.23

Previous close

226.61

News Sentiment

By Acuity

16%

84%

20 / 350 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Mar 2026, 18:58 UTC

Major Market Movers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 Mar 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 Mar 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 Mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 Mar 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 Mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 Mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 Mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 Mar 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

24 Mar 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 Mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 Mar 2026, 20:58 UTC

Major News Events

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 Mar 2026, 20:50 UTC

Market Talk
Major News Events

Energy & Utilities Roundup: Market Talk

24 Mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

24 Mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

24 Mar 2026, 20:25 UTC

Earnings

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 Mar 2026, 20:15 UTC

Market Talk
Major News Events

Global Commodities Roundup: Market Talk

24 Mar 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 Mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Sales $378.7M >WOR

24 Mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 Mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q EPS 92c >WOR

24 Mar 2026, 19:25 UTC

Market Talk
Major News Events

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 Mar 2026, 19:06 UTC

Market Talk
Major News Events

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 Mar 2026, 18:51 UTC

Market Talk
Major News Events

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 Mar 2026, 18:40 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

24 Mar 2026, 18:40 UTC

Market Talk
Major News Events

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 Mar 2026, 18:34 UTC

Major News Events

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 Mar 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 Mar 2026, 18:21 UTC

Market Talk
Major News Events

Silver Snaps 9-Session Losing Streak -- Market Talk

24 Mar 2026, 18:00 UTC

Acquisitions, Mergers, Takeovers

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

29.8% upside

12 Months Forecast

Average 296.2 USD  29.8%

High 345 USD

Low 265 USD

Based on 12 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

7

Buy

5

Hold

0

Sell

Sentiment

By Acuity

20 / 350 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat